Hudson Bay Capital Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.81M Sell
220,000
-75,000
-25% -$616K 0.01% 567
2025
Q1
$2.11M Sell
295,000
-13,100
-4% -$93.7K 0.01% 511
2024
Q4
$2.38M Buy
308,100
+93,100
+43% +$720K 0.01% 472
2024
Q3
$2.26M Buy
215,000
+50,000
+30% +$525K 0.01% 413
2024
Q2
$1.93M Buy
165,000
+120,100
+267% +$1.41M 0.01% 431
2024
Q1
$946K Sell
44,900
-45,100
-50% -$950K 0.01% 457
2023
Q4
$1.62M Sell
90,000
-25,000
-22% -$449K 0.01% 408
2023
Q3
$1.89M Buy
115,000
+30,000
+35% +$494K 0.01% 420
2023
Q2
$1.7M Buy
85,000
+24,200
+40% +$484K 0.01% 463
2023
Q1
$1.15M Buy
60,800
+15,800
+35% +$299K 0.01% 534
2022
Q4
$1.02M Buy
45,000
+25,000
+125% +$567K 0.01% 646
2022
Q3
$529K Sell
20,000
-50,000
-71% -$1.32M ﹤0.01% 849
2022
Q2
$1.73M Buy
70,000
+5,000
+8% +$124K 0.01% 794
2022
Q1
$2.16M Hold
65,000
0.03% 662
2021
Q4
$2.13M Buy
65,000
+15,000
+30% +$491K 0.02% 643
2021
Q3
$2.1M Sell
50,000
-27,500
-35% -$1.15M 0.03% 591
2021
Q2
$3.01M Buy
77,500
+31,360
+68% +$1.22M 0.04% 488
2021
Q1
$1.57M Buy
46,140
+6,140
+15% +$209K 0.02% 602
2020
Q4
$1.81M Sell
40,000
-223,000
-85% -$10.1M 0.02% 388
2020
Q3
$7.24M Buy
263,000
+43,000
+20% +$1.18M 0.11% 157
2020
Q2
$8.1M Buy
220,000
+95,000
+76% +$3.5M 0.14% 122
2020
Q1
$4.05M Sell
125,000
-15,000
-11% -$486K 0.1% 176
2019
Q4
$5.74M Buy
140,000
+50,406
+56% +$2.07M 0.13% 141
2019
Q3
$3.19M Buy
+89,594
New +$3.19M 0.09% 199
2018
Q3
Sell
-40,000
Closed -$2.87M 586
2018
Q2
$2.87M Sell
40,000
-50,000
-56% -$3.59M 0.04% 233
2018
Q1
$2.69M Buy
90,000
+15,000
+20% +$448K 0.06% 213
2017
Q4
$2.49M Buy
75,000
+55,000
+275% +$1.83M 0.05% 196
2017
Q3
$659K Buy
+20,000
New +$659K 0.02% 254